Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Message transfer apparatus, output method, and computer program product
Magnesium metal-air battery
System and method for agitation of multiple specimen containers
Liquid composite compositions using non-volatile liquids and nanoparticles and uses thereof
Registration and network access control
Multi-carrier operation for wireless systems
Arcuate motion control in electrostatic actuators
  Randomly Featured Patents
Toothbrush for children
Vehicle roof having externally running sliding roof
Semiconductor integrated circuit device having single-element type nonvolatile memory elements
Injection molding apparatus with nozzle advanceable to mount side gate seals
Aerodynamic fork mast structure
Method for making polyarylene ether - polyalkenamer copolymers and products
Seal assembly, its use and installation
Synthetic resin bag having an easy opening function
Memory initialization by performing parallel execution of firmware and kernel by different CPUs
Rapidly making complex castings